CRISPR/Cas9 knockout of human arylamine N-acetyltransferase 1 in MDA-MB-231 breast cancer cells suggests a role in cellular metabolism

Human arylamine N-acetyltransferase 1 (NAT1), present in all tissues, is classically described as a phase-II xenobiotic metabolizing enzyme but can also catalyze the hydrolysis of acetyl-Coenzyme A (acetyl-CoA) in the absence of an arylamine substrate using folate as a cofactor. NAT1 activity varies...

Descripción completa

Detalles Bibliográficos
Autores principales: Carlisle, Samantha M., Trainor, Patrick J., Hong, Kyung U., Doll, Mark A., Hein, David W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7299936/
https://www.ncbi.nlm.nih.gov/pubmed/32555504
http://dx.doi.org/10.1038/s41598-020-66863-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7299936/
https://www.ncbi.nlm.nih.gov/pubmed/32555504
http://dx.doi.org/10.1038/s41598-020-66863-4

Ejemplares similares